Hemodynamic and electroencephalographic effects of remifentanil during induction and tracheal intubatio
Not Applicable
- Conditions
- on-specific
- Registration Number
- JPRN-UMIN000002315
- Lead Sponsor
- Osaka City University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with severe liver or renal dysfunction, bronchial asthma, receiving cytochrome P450 inducer or inhibitors, morbid obesity, predicted difficult intubation, seizure, consciousness disturbance, receiving medications affecting electroencephalogram, hypotension, heart failure, coronary artery disease or history of abnormal reactions by midazolam or remifentanil
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method blood pressure, heart rate, bispectral index, 95% spectral edge frequency
- Secondary Outcome Measures
Name Time Method electroencephalographic power in delta, theta, alpha and beta band